Lipocine Inc. financial data

Symbol
LPCN on Nasdaq
Location
Salt Lake City, United States
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1243% % 2.2%
Debt-to-equity 8.7% % -2.6%
Return On Equity -31% % -60%
Return On Assets -28% % -60%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,551,931 shares 3.8%
Common Stock, Shares, Outstanding 5,420,256 shares 1.4%
Entity Public Float $42,800,000 USD 67%
Common Stock, Value, Issued $8,870 USD 0.08%
Weighted Average Number of Shares Outstanding, Basic 5,413,149 shares 1.2%
Weighted Average Number of Shares Outstanding, Diluted 5,413,149 shares 1.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $114,574 USD
Research and Development Expense $6,978,990 USD -12%
General and Administrative Expense $3,653,802 USD -31%
Operating Income (Loss) $6,310,100 USD -19%
Nonoperating Income (Expense) $835,062 USD -33%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,475,038 USD -35%
Income Tax Expense (Benefit) $200 USD 0%
Net Income (Loss) Attributable to Parent $5,475,238 USD -35%
Earnings Per Share, Basic -0.59 USD/shares -44%
Earnings Per Share, Diluted -0.59 USD/shares -34%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,901,040 USD 4.2%
Assets, Current $15,930,140 USD -22%
Property, Plant and Equipment, Net $119,274 USD -30%
Other Assets, Noncurrent $23,753 USD 0%
Assets $16,073,167 USD -22%
Accounts Payable, Current $861,452 USD 202%
Accrued Liabilities, Current $749,667 USD -42%
Liabilities, Current $1,931,119 USD 22%
Liabilities $1,931,119 USD 22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,627 USD -53%
Retained Earnings (Accumulated Deficit) $207,026,283 USD -2.7%
Stockholders' Equity Attributable to Parent $14,142,048 USD -26%
Liabilities and Equity $16,073,167 USD -22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,969,257 USD -182%
Net Cash Provided by (Used in) Investing Activities $882,073 USD 78%
Common Stock, Shares Authorized 75,000,000 shares -62%
Common Stock, Shares, Issued 5,420,592 shares 1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,851,330 USD -69%
Deferred Tax Assets, Valuation Allowance $48,222,797 USD 0.98%
Deferred Tax Assets, Gross $48,231,575 USD 0.98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,480,553 USD -36%
Lessee, Operating Lease, Liability, to be Paid $157,200 USD 2.5%
Property, Plant and Equipment, Gross $1,388,372 USD 6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $62,880 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $62,880 USD 2.5%
Additional Paid in Capital $221,195,546 USD 0.23%